Friedreich' s Ataxia gene therapy(Voyager Therapeutics)

N/A

Report date: 2024/03/27 17:50:06

Base Information

Drug NameFriedreich' s Ataxia gene therapy(Voyager Therapeutics)
Drug Alias NameFXN Gene Therapy (Voyager Therapeutics)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionFrataxin Gene transference
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoyager Therapeutics IncNeurocrine Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Therapeutics LtdVoyager Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A